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ABSTRACT 
Objective: We sought to validate the vasoactive-ventilation-renal (VVR) score, a novel disease 
severity index, as a predictor of outcome in a multicenter cohort of neonates who underwent 
cardiac surgery.   
Design: Retrospective chart review  
Setting: Seven tertiary care referral centers 
Patients: Neonates defined as age less than or equal to 30 days at the time of cardiac surgery 
Interventions: Ventilation index (VI), vasoactive-inotrope score (VIS), serum lactate, and VVR 
score were recorded for three postoperative time points: ICU admission, 6 hours and 12 hours.  
Peak values, defined as the highest of the three measurements, were also noted.  VVR was 
calculated as follows: VI + VIS + Δ creatinine [change in creatinine from baseline*10].  Primary 
outcome was prolonged duration of mechanical ventilation, defined as greater than 96 hours.   
Receiver operative characteristic curves were generated and abilities of variables to correctly 
classify prolonged duration of mechanical ventilation were compared using area under the curve 
(AUC) values.  Multivariable logistic regression modelling was also performed.  
Measurements and Main Results: We reviewed 275 neonates. Median age at surgery was 7 
days (25%,75%: 5,12), 86 (31%) had single ventricle anatomy, and 183 (67%) were classified 
as STAT mortality category 4 or 5.  Prolonged duration of mechanical ventilation occurred in 89 
patients (32%).  At each postoperative time point, the AUC for prolonged duration of mechanical 
ventilation were significantly greater for the VVR score as compared to the VI, VIS, and serum 
lactate, with an AUC for peak VVR score of 0.82 (95% CI: 0.77,0.88).  On multivariable analysis, 
peak VVR score was independently associated with prolonged duration of mechanical 
ventilation, odds ratio (per 1-unit increase): 1.08 (95% confidence interval: 1.04,1.12).   
Conclusions: In this multicenter cohort of neonates who underwent cardiac surgery, the VVR 
score was a reliable predictor of postoperative outcome and outperformed more traditional 
measures of disease complexity and severity.  
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Article Tweet 
In this multicenter study, we validated the VVR score as a reliable predictor of postoperative 
outcome in neonates who underwent cardiac surgery. 
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INTRODUCTION 
Neonates who undergo surgery for congenital heart disease are known to be at significant risk 
for postoperative morbidity and mortality (1-7).  Although potential adverse outcomes have been 
well-described, the ability to identify patients at increased risk for poor outcomes has been 
challenging, in large part due to heterogeneity of the patients’ anatomy and pathophysiology.  
Disease severity indices that quantify clinical data obtained within the early postoperative period 
and predict postoperative outcomes can have considerable utility and are sorely needed. 
 
The vasoactive-ventilation-renal (VVR) score is a novel disease severity index that incorporates 
validated markers of cardiovascular, pulmonary, and renal function.  In single center studies, it 
has been shown to be a robust predictor of outcomes in heterogenous populations of children 
recovering from surgery for congenital heart disease (8-10).   These studies have included 
neonates (8-10), children with cyanotic congenital heart disease (9-10), children undergoing 
cardiopulmonary bypass (8-10), children not undergoing cardiopulmonary bypass (9-10), and 
adults with congenital heart disease (10).  Most recently, the VVR score obtained at 12 hours 
postoperatively was shown to be a strong predictor of postoperative hospital length of stay and 
outperformed more traditional indices of disease complexity and illness severity including STAT 
mortality category, duration of cardiopulmonary bypass, vasoactive-inotrope score, ventilation 
index, and serum lactate (10).  
   
For this study, we sought to perform the first multicenter validation of the VVR score utilizing a 
dataset containing neonates who underwent cardiac surgery at seven tertiary care centers 
within the United States (11). We hypothesized that the VVR would be a reliable predictor of 
outcome in this patient population and continue to outperform more traditional measures of 
disease complexity and severity.  
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METHODS 
Design and Setting 
The study was a retrospective multicenter cohort study. We collected additional data on 
neonates who had previously been prospectively enrolled in an observational study examining 
extubation failure after neonatal cardiac surgery from January 1, 2015 through December 31, 
2015 (11).  Patients were enrolled from the following institutions: Riley Hospital for Children at 
Indiana University Health, Indianapolis, Indiana (coordinating center); Children’s Hospital of 
Michigan, Detroit, Michigan; Cleveland Clinic, Cleveland, Ohio; Arnold Palmer Hospital for 
Children, Orlando, Florida; Phoenix Children’s Hospital, Phoenix, Arizona; Ann & Robert H. 
Lurie Children’s Hospital of Chicago, Illinois; and American Family Children’s Hospital, Madison, 
Wisconsin. The study was approved by the institutional review boards at all participating 
centers. Because of the observational nature of the data collected, the need for informed 
consent was waived. 
 
Study Population 
All neonates, defined as less than or equal to 30 days of age, who underwent pediatric cardiac 
surgery (with or without cardiopulmonary bypass) were reviewed. Neonates less than 2.5 kg 
who underwent ligation of the patent ductus arteriosus, patients with incomplete data for key 
exposure and outcome variables or patients placed on extracorporeal membrane oxygenation 
(ECMO) in the operating room prior to ICU arrival were excluded. 
 
Data Collection 
Data were collected via medical record review. Demographic and preoperative data collection 
included: age; sex; anthropometric data; estimated gestational age at birth; underlying 
cardiovascular diagnoses; presence of genetic anomalies; presence of non-cardiac anatomic 
anomalies; need for preoperative mechanical ventilation; and the occurrence of preoperative 
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shock, infection, necrotizing enterocolitis, stroke or seizure.   Perioperative data collected 
included: surgical procedure performed; Society of Thoracic Surgeons - European Association 
for Cardio-Thoracic Surgery Congenital Heart Surgery Mortality Categories (i.e., STAT Mortality 
Category) (4); duration of cardiopulmonary bypass and aortic cross clamping; and use of deep 
hypothermic arrest or antegrade cerebral perfusion.  Postoperative data collected included: 
need for ECMO, inhaled nitric oxide therapy, CPR; presence of postoperative open sternotomy; 
or the occurrence of arrhythmias, acute kidney injury, infection, necrotizing enterocolitis, stroke, 
or seizure. We recorded mechanical ventilation parameters, arterial blood gas and lactate 
measurements, and doses of inotropic and vasopressor medications at three postoperative time 
points: ICU admission and 6 hours and 12 hours after ICU arrival. We also recorded 
preoperative serum creatinine and all serum creatinine measurements obtained within the first 
12 postoperative hours.   
 
Derivation of the VVR  
The derivation of the VVR score has been described in detail elsewhere (8-10).  In short, 
vasoactive inotrope score [VIS = dopamine dose (mcg/kg/min) + dobutamine dose (mcg/kg/min) 
+ 100 * epinephrine dose (mcg/kg/min) + 10 * milrinone dose (mcg/kg/min) + 10,000 * 
vasopressin dose (U/kg/min) + 100 * norepinephrine dose (mcg/kg/min)] and ventilation index 
[VI = (Ventilator RR)*(PIP-PEEP)*PaCO2 / 1000] were calculated at each postoperative time 
point.(12-15)  VI and VIS were recorded as zero for patients not receiving mechanical ventilation 
or inotropic support, respectively.   Baseline preoperative serum creatinine was subtracted from 
each postoperative serum creatinine measurement which we labeled ΔCr.  Admission values 
were typically utilized for admission and 6-hour VVR calculations and postoperative day 1 
values were typically used for 12-hour values. For patients in which postoperative serum 
creatinine measurements were less than or equal to baseline, ΔCr = 0.  VVR scores were 
calculated as follows: VI + VIS + Δcreatinine [change in serum creatinine from baseline*10].   
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Outcomes 
Our primary outcome variable was prolonged duration of mechanical ventilation, defined as 
greater than or equal to 96 hours based on previously published data of neonates recovering 
from cardiac surgery and ICD-10-CM procedure code 5A1955Z (16,17).  Measurements 
obtained after extubation from mechanical ventilation were not included in analyses focused on 
identifying predictor variables for prolonged mechanical ventilation.  Secondary outcomes of 
interest were ICU length-of-stay (LOS), hospital LOS, and mortality.  For secondary analyses, 
we defined prolonged duration of hospital LOS was defined as greater than 30 days or death 
prior to 30 days postoperatively. 
 
Statistical Analysis  
Descriptive statistics were used to characterize the patient population.  Data are provided as 
median (25%,75%) for continuous variables and absolute counts with percentages for 
categorical variables.  Bivariate comparisons of variables and outcomes in patients with and 
without prolonged duration of mechanical ventilation were performed using Wilcoxon rank-sum, 
chi-square, or Fisher exact tests as appropriate for individual variables.   Receiver operating 
characteristic curves were generated and areas under the curve (AUC) with 95% confidence 
intervals (CI) were calculated for prolonged duration of mechanical ventilation and VI, VIS, VVR, 
and serum lactate at all study time points, as well as for STAT mortality category and duration of 
cardiopulmonary bypass.   Data for patients who were extubated prior to each postoperative 
time point were not included in the ROC analyses of data from time points following their 
liberation from mechanical ventilation.  AUC values were compared using the method of 
DeLong, DeLong, and Clarke-Pearson as implemented by SAS.(18)  
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For the multivariable regression analysis, variables with significance of 0.20 or less on bivariate 
comparison were considered for inclusion in the model.  We also performed univariate and 
multivariable regression analyses to determine independent predictors of prolonged hospital 
LOS.  Linearity in the logit was examined for continuous variables before model building; 
variables with evidence of nonlinearity were converted to categorical variables. To obtain the 
best model, stepwise selection was used with a significance level of 0.2 for entry into the model 
and 0.05 for staying in the model.  The multivariable logistic model for our primary outcome 
variable, prolonged duration of mechanical ventilation, was also analyzed as a mixed model with 
a random effect for center.  For these analyses, VVR scores were analyzed first as a continuous 
variable and secondly as a categorical variable using results of ROC characteristic results to 
identify appropriate cut points that maximize total accuracy and minimize weighted error ratios.  
The results of all multivariable analyses are provided as odds ratios (OR) with 95% confidence 
intervals (CI).  All statistical analyses were performed with Stata version 14 (Stata Corp, College 
Station, Texas) and SAS version 9.4 (SAS Institute, Cary, North Carolina.)  
 
RESULTS 
We reviewed 293 patients, of which 16 were excluded due to ECMO initiation in the operating 
room and 2 were excluded due to incomplete data.  The study population therefore consisted of 
275 neonates, of which 173 (63%) were male, 41 (15%) were premature, and 43 (16%) had a 
genetic anomaly. The median age at surgery was 7 days (5, 12) and median weight was 3.2 kg 
(2.9, 3.6). Eighty-six neonates (31%) had single ventricle anatomy, 183 (67%) were STAT 
mortality category 4 or 5, and 71 (26%) required preoperative mechanical ventilation.  Deep 
hypothermic circulatory arrest or antegrade cerebral perfusion was employed in 107 (39%) of 
patients and delayed sternal closure was used in 85 neonates (31%), including 36 recovering 
from the Norwood operation.  Additional data describing the study population is provided in 
Table 1. 
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Prolonged duration of mechanical ventilation occurred in 89 (32%) neonates.  No patients died 
while receiving mechanical ventilation within 96 hours of surgery.  Neonates with prolonged 
duration of mechanical ventilation were more likely to be premature, have non-cardiac anatomic 
anomalies, have received preoperative mechanical ventilation, have single ventricle anatomy, 
and be classified into a higher STAT Mortality Category (Table 1). Neonates with prolonged 
duration of mechanical ventilation were also more likely to have longer median cardiopulmonary 
bypass duration, received deep hypothermic circulatory arrest or antegrade cerebral perfusion, 
undergone delayed sternal closure, received inhaled nitric oxide, and experienced postoperative 
arrhythmias (Table 2). 
 
Serum lactate, VIS, VI, and VVR measurements for all three postoperative time points and peak 
values are summarized in Table 3.  Two patients were extubated in the operating room prior to 
ICU admission and were not included in these analyses.  Four patients who were extubated 
between admission and 6-hours postoperatively and four patients who were extubated between 
6 and 12 hours postoperatively were excluded from analyses of data obtained at 6-hours and 
12-hours, respectively.  The AUC values resulting from ROC characteristic analysis of each 
variable as predictors of prolonged duration of mechanical ventilation are also provided in Table 
3.  In this analysis, the VVR performed well with significantly greater AUC values than the 
corresponding VI, VIS and lactate.  ROC curves for prolonged duration of mechanical ventilation 
and STAT Mortality Category, cardiopulmonary bypass duration, and peak VI, VIS, serum 
lactate, and VVR score are illustrated in Figure 1. 
 
AUC values for VVR score at 6-hours and 12-hours postoperatively and peak VVR score were 
not statistically different, though all three AUC values were significantly greater than the AUC for 
VVR score at admission.  For the multivariable analysis, we opted to examine peak VVR score 
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which, unlike VVR score at 6 and 12 hours postoperatively, included measurements from all 273 
patients who arrived to the ICU receiving mechanical ventilation (i.e., did not exclude any patient 
extubated between admission and 12 hours postoperatively).  The results of the mixed 
multivariable regression analysis, which includes adjustments for random center effect, are 
shown in Table 4.   Peak VVR score remained a strong independent predictor of prolonged 
duration of ventilation. Specifically, with each increase of 1 point in a patient’s peak VVR score, 
the odds of prolonged duration of mechanical ventilation increased by 8% (OR: 1.08; 95% CI 
1.04-1.12).  Additional variables that were independently associated with prolonged duration of 
mechanical ventilation were prematurity, preoperative mechanical ventilation, delayed sternal 
closure, postoperative inhaled nitric oxide use, and postoperative arrhythmia.   ROC curves for 
the model and its individual components are shown in Figure 2. The AUC for the mixed model 
(which includes adjustment for possible center effect) is 0.92 (95% CI: 0.89, 0.96).   
 
To simplify interpretation of the VVR score as a predictor of prolonged DMV, we repeated the 
multivariable analysis using peak VVR score as a categorical variable, with a cutoff value of 35 
identified based on ROC characteristic analysis.  For neonates with a peak VVR score greater 
than or equal to 35, odds of prolonged duration of mechanical ventilation were more than three 
times that of patients with peak VVR score less than 35 (OR: 3.4; 95% CI 1.7-7.1).   Further, 
patients with peak VVR greater than or equal to 35 had significantly longer postoperative ICU 
and hospital stay, and increased mortality (Table 5). 
 
In the study population, 80 patients were considered to have prolonged postoperative hospital 
LOS:  78 patients required greater than 30 days of hospitalization after surgery and 2 patients 
died prior to 30 days postoperatively.  Results of the multivariable analysis of this secondary 
outcome variable, unadjusted for center, are provided in Table 6.  Peak VVR at 12 hours 
postoperatively was independently associated with prolonged LOS, along with genetic and non-
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cardiac abnormalities, single ventricle anatomy, preoperative mechanical ventilation, and the 
presence of clinically significant residual cardiac lesions.  In a similar multivariable model that 
included the aforementioned variables but with peak VVR greater than or equal to 35 as a 
categorical variable, odds of prolonged LOS in neonates with a peak VVR score greater than or 
equal to 35 were more than three times that of the rest of the cohort (OR: 3.8; 95% CI 2.0-7.3). 
  
DISCUSSION  
The VVR score was conceived as a multiorgan system severity of illness index for patients 
recovering from surgery for congenital or acquired heart disease that could improve upon 
traditional indices such as the VIS and serum lactate.  While these latter measures have been 
demonstrated to be predictive of outcome in this patient population (12-14,19), they are 
primarily reflective of postoperative cardiovascular health and do not quantify the contributions 
of other organ systems to postoperative disease acuity.  Based on this concern, it was therefore 
hypothesized that a disease severity index containing measures of cardiovascular, respiratory, 
and renal function would be more reflective of the burden of illness being experienced by these 
fragile children.  This hypothesis was proven correct in the several single center studies, in 
which the VVR was demonstrated to be a robust predictor of postoperative outcomes including 
prolonged duration of mechanical ventilation and postoperative length of stay.(8-10)  Further, 
VVR measurements obtained at 6 and 12 hours postoperatively were identified as being more 
predictive of poor outcome than those obtained at admission, 24 and 48 hours. 
     
After the initial single center work examining the VVR, this multicenter validation study was the 
logical next step.  To accomplish this goal, we were able to utilize and add to data obtained in a 
previous prospective multicenter study of neonates who underwent cardiac surgery.  From 
these data, we demonstrated that the peak VVR score obtained during the first 12 hours after 
admission was most predictive of prolonged duration of mechanical ventilation.  Consistent with 
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prior studies, the VVR score was superior to the VIS alone, ventilation index alone, serum 
lactate, STAT Mortality Category, and duration of cardiopulmonary bypass as a predictor of 
postoperative duration of mechanical ventilation and hospital length of stay.  It is not surprising 
that the additional of postoperative ventilatory and to the VIS improved the ability to predict 
prolonged duration of mechanical ventilation. It was also not unexpected to find that 
quantification of postoperative disease severity is more predictive of postoperative outcome 
than pre- or intraoperative measures of disease complexity. The finding that the VVR score is 
more predictive of prolonged duration of mechanical ventilation than the ventilation index alone 
however is particularly notable, as it supports the notion that organ systems other than the 
respiratory system have a significant contribution to the postoperative ventilatory needs of this 
patient population.  Despite our findings, we are not asserting that the VIS, ventilation index, or 
serum lactate have no value and should be abandoned in favor of the VVR, nor are we implying 
that our findings lessen the importance of STAT mortality category as the current standard for 
assessment of surgical complexity for children with congenital heart disease.  On the contrary, 
we believe that the VVR should be added to this armamentarium of indices as a more 
comprehensive measure of postoperative disease severity. 
 
In the most recent single center VVR study, a VVR score greater than 25 was identified as the 
best cutoff point distinguishing between children who were at risk for poor postoperative 
outcome and children who were not (10).  Not surprisingly, in a cohort of patients that included 
only neonates, who tend to be more complex (i.e. 67% were classified as STAT Mortality 
Category 4 or 5), a peak VVR score greater than or equal to 35 was determined as the optimal 
cutoff value to identify patients most at risk for prolonged duration of mechanical ventilation.  
Moreover, peak VVR score greater than or equal to 35 within the first 12 hours of admission 
remained independently associated with prolonged duration of mechanical ventilation in a model 
that included several additional variables frequently associated with an extended postoperative 
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course:  prematurity, preoperative mechanical ventilation, delayed sternal closure, use of 
inhaled nitric oxide, and the occurrence of postoperative arrhythmias (20-26).     
 
We opted to focus on the prolonged duration of mechanical ventilation as our measure of poor 
outcome in this study rather than prolonged length of stay or mortality for several reasons.  First, 
there is a formal ICD-10 code for duration of mechanical ventilation greater than 96 hours, while 
no specific ICD-10 code or accepted definition exists for prolonged ICU or hospital stay.  
Interestingly, we found that 32% of patients within our cohort were classified by this ICD-10 
code as having prolonged duration of mechanical ventilation, which is close to the upper 25% 
chosen in prior studies of the VVR (8-10).  Our definition for prolonged duration of mechanical 
ventilation is further justified by data from a recent a large multicenter cohort of neonates 
recovering from cardiac surgery, which reported a median duration of mechanical ventilation of 
70 hours (17). We were also aware that all but two of the patients were endotracheally intubated 
on mechanical ventilation upon arrival to the ICU.  Indeed, prolonged duration of mechanical 
ventilation as an outcome measure would not have been ideal in a study in which a notable 
portion of patients were extubated in the operating room.  Lastly, the low operative mortality rate 
in our study (4%) precluded our ability to evaluate the VVR and other variables as predictors of 
this outcome. With lower operative mortality for congenital heart surgery in the current era, 
morbidity and resource consumption are receiving greater attention. We did however observe 
that postoperative ICU and hospital stay in patients with VVR score greater or equal to 35 were 
nearly twice that of patients with VVR score less than 35, while risk-adjusted operative mortality 
in patients with VVR score greater than or equal to 35 was nearly three times that of the rest of 
the cohort.  A study with a greater absolute number of operative deaths would be required to 
further examine the ability of the VVR to predict mortality.  
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The VVR score has many practical bedside applications.  VVR scores obtained early in the 
postoperative course could allow clinicians to effectively quantitate disease severity and provide 
a reliable estimate of duration of mechanical ventilation and postoperative ICU and hospital stay 
to parents and staff. Likewise, these data could assist clinicians, nursing administrators, and 
respiratory therapists with resource allocation and quality improvement initiatives.  
Academically, the VVR score has potential as a means of risk assessment, adjustment, and 
stratification in clinical research.  On the other hand, though these data and earlier studies are 
promising, further validation in a multicenter data set that includes patients outside of the 
neonatal period should be conducted before widespread applications of the VVR score can be 
recommended.    
 
This study contains the limitations inherent to a retrospective study design.  Additionally, the VI, 
VIS, and VVR score cannot be reliably calculated for patients on ECMO, as these indices are 
not reflective of disease severity in this patient population.  The use of EMCO however, in and 
of itself, is a significant risk factor for poor outcome in this patient population (27,28).  Further, 
because of the notable differences in outcomes in neonates and children who do and do not 
require ECMO after cardiac surgery, studies attempting to identify risk factors for poor outcomes 
in patients who require ECMO should consider focusing exclusively on this subgroup. It is also 
important to note that creatinine values within the neonatal population may be affected by 
maternal creatinine. Finally, vasoactive medication administration, ventilator support, and 
extubation readiness assessment were not protocolized, and as a result, were likely affected by 
variation in physician practice.  Moreover, differences in intraoperative management may lead to 
differences postoperative vasoactive and ventilatory needs, as well as differences in early 
serum creatinine measurements after infant heart surgery (29). It is therefore encouraging that 
the VVR remained independently associated with prolonged duration of mechanical ventilation 
after adjustment for center effects. 
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CONCLUSION 
In a multicenter population of neonates undergoing surgery for congenital heart disease, the 
VVR calculated in the early postoperative recovery period was a reliable predictor of prolonged 
mechanical ventilation and outperformed more traditional measures of disease complexity and 
severity.  Neonates with a peak VVR greater than or equal to 35 within the first 12 postoperative 
hours after cardiac surgery should be considered at increased risk for a more complicated 
postoperative course.  
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Table 1.  Demographic, Anthropometric, and Preoperative Data 
Variable All patients (N=275) 
DMV ≤ 96h 
(n=186) 
DMV > 96h 
(n=89) P-value
a 
Age at surgery (days) 7 (5,12) 7 (5, 13) 7 (5, 11) 0.62 
Weight (kg) 3.2 (2.9, 3.6) 3.3 (3, 3.7) 3 (2.6, 3.4) <0.001 
Sex (male) 173 (63) 119 (64%) 54 (61%) 0.60 
Prematurity, < 37 weeks  41 (15%) 20 (11%) 21 (24%) 0.005 
Genetic anomaly  43 (16%) 24 (13%) 19 (21%) 0.07 
Non-cardiac anatomic anomalies 39 (14%) 20 (11%) 19 (21%) 0.02 
Airway / respiratory anomaly 15 (5%) 8 (4%) 7 (8%) 0.26 
Neurologic anomaly or insult b 19 (7%) 11 (6%) 8 (9%) 0.35 
Mechanical ventilation c 71 (26%) 35 (19%) 36 (40%) < 0.001 
Shock  39 (14%) 23 (12%) 16 (18%) 0.21 
Infection 15 (5%) 10 (5%) 5 (6%) 1.0 
Necrotizing enterocolitis  7 (3%) 4 (2%) 3 (3%) 0.69 
Single ventricle anatomy  86 (31%) 47 (25%) 39 (44%) 0.002 
 Hypoplastic left heart  52 (19%) 21 (11%) 31 (35%) <0.001 
 Hypoplastic right heart  24 (9%) 21 (11%) 3 (3%) 0.03 
 Heterotaxy  10 (4%) 5 (3%) 5 (6%) 0.30 
  STAT Mortality Category  
 1 
 2 
 3 
 4 
 5 
 
5 (2%) 
42 (15%) 
45 (16%) 
136 (49%) 
47 (17%) 
 
5 (3%) 
36 (19%) 
34 (18%) 
91 (49%) 
20 (11%) 
 
0 (0%) 
6 (7%) 
11 (12%) 
45 (51%) 
27 (30%) 
<0.001 
0% 
14% 
24% 
33% 
57% 
Continuous variables represented as mean (standard deviation) or median (25th%, 75th%); 
categorical data represented as absolute counts (%) 
aComparing DMV≤96 hours to DMV>96 hours 
b Underlying neuroanatomic anomaly, or stroke or seizures prior to surgery 
C Received mechanical ventilation until day of surgery 
DMV: Duration of mechanical ventilation , STAT: Society of Thoracic Surgeons-European 
Association for Cardio-Thoracic Surgery Congenital Heart Surgery Mortality Category 
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Table 2.  Perioperative and ICU Admission Data 
Variable All patients (N=275) 
DMV ≤ 96h 
(n=186) 
DMV > 96h 
(n=89) P-value
a 
  Cardiopulmonary bypass (min) 129 (0, 184) 119 (0,162) 150 (84, 217) <0.001 
  Aortic cross clamp (min) 51 (16, 90) 42 (15, 89) 60 (29, 92) 0.09 
  DHCA  67 (24%) 39 (21%) 28 (31%) 0.06 
  ACP  75 (27%) 41 (22%) 34 (38%) 0.005 
  DHCA or ACP  107 (39%) 62 (33%) 45 (51%) 0.006 
  Delayed sternal closure  85 (31%) 28 (15%) 57 (64%) <0.001 
  Inhaled nitric oxide use  58 (21%) 20 (11%) 38 (43%) <0.001 
  Postoperative arrhythmias  68 (25%) 32 (17%) 36 (40%) <0.001 
Continuous variables represented as mean (standard deviation) or median (25th%, 75th%); 
categorical data represented as absolute counts (%) 
aComparing DMV≤96 hours to DMV>96 hours 
DMV: Duration of mechanical ventilation, ACP: antegrade cerebral perfusion; DHCA: Deep 
hypothermic circulatory arrest 
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Table 3.  ROC Analysis of Predictive Variables and Prolonged DMV 
Postoperative Variables Median (IQR) Maximum AUC (95% CI) 
Admit:    
 Lactate (mg/dL) 3 (1.7 - 5) 13.1 0.68 (0.61 - 0.75) 
 VIS 8 (5 - 11) 30 0.69 (0.62 - 0.76) 
 VI 19 (15 - 25) 112  0.72 (0.66 - 0.79) 
 VVR Score 28 (22 - 38) 127 0.78 (0.73 - 0.84) 
6-hours:    
 Lactate (mg/dL) 2.7 (1.6 - 4.1) 13.4 0.68 (0.61 - 0.75) 
 VIS 8 (5 - 11) 37 0.68 (0.61 - 0.75) 
 VI 17 (13 - 22) 96 0.76 (0.70 - 0.82) 
 VVR Score 27 (21 - 34) 109 0.81 (0.75 - 0.86) 
12-hours:    
 Lactate (mg/dL) 2.2 (1.5 - 3.2) 11.6 0.66 (0.59 - 0.73) 
 VIS 8 (5 - 12) 64 0.69 (0.62 - 0.75) 
 VI 16 (12 - 21) 74 0.74 (0.67 - 0.80) 
 VVR Score 26 (20 - 34) 92 0.82 (0.76 - 0.87) 
Peak in 12 hours:    
 Lactate (mg/dL) 3.7 (2.3 - 5.3) 13.4 0.69 (0.62 - 0.76) 
 VIS 10 (6 - 13) 64 0.70 (0.63 - 0.77)  
 VI 21 (16 - 27) 112 0.78 (0.71 - 0.84) 
 VVR Score 31 (24 - 40) 127 0.82 (0.77 - 0.88) 
STAT Mortality Category 4 (3 - 4) 5 0.66 (0.60 - 0.72) 
CPB duration (min) 129 (0, 184) 413 0.64 (0.57 - 0.71) 
AUC: Area under the receiver operating characteristic curve; CPB: cardiopulmonary bypass; CI: 
confidence interval; IQR: interquartile range; DMV: Duration of mechanical ventilation , STAT: 
Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery Congenital 
Heart Surgery mortality category; VI: ventilation index; VIS: vasoactive inotrope score; VVR: 
vasoactive-ventilation-renal score 
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Table 4.  Multivariate Logistic Regression Analysis for Predictors of Prolonged Duration of 
Mechanical Ventilation (Mixed model adjusted for possible random effect of center) 
Variable Odds Ratio (95% Confidence Interval) P-value 
Prematurity (< 37 weeks) 3.5 (1.3 – 9.1) 0.012 
Preoperative ventilation 5.3 (2.2 – 12.7) <0.001 
Delayed sternal closure 10.8 (4.2 – 28.2) <0.001 
Inhaled nitric oxide use 4.6 (1.6 – 13.2) 0.005 
Postoperative arrhythmias 3.2 (1.4 – 7.6) 0.007 
Peak VVR in 1st 12 hours 1.08 (1.04 – 1.12) <0.001 
VVR: vasoactive-ventilation-renal score 
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Table 5.  Clinical Outcomes 
Outcome Peak VVR < 35 (n=169) 
Peak VVR ≥ 35 
(n=104) P-value 
Duration of ventilation (days) 3 (1, 4) 6 (4, 15) <0.001 
ICU stay (days) 8 (4, 15) 14 (9, 32) <0.001 
Hospital stay (days) 14 (9, 25) 29 (18, 50) <0.001 
Mortality  3 (2%) 9 (9%) 0.01 
Continuous variables represented as median (25th%, 75th%); categorical data represented as 
absolute counts (percentages) 
ICU: intensive care unit, VVR: vasoactive-ventilation-renal score 
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Table 6.  Multivariate Logistic Regression Analysis for Predictors of Prolonged Hospital Length-
of-Stay 
Variable Odds Ratio (95% Confidence Interval) P-value 
Genetic anomalies 3.3 (1.4 – 7.8) 0.008 
Non-cardiac abnormalities 5.0 (2.1 – 12.1) <0.001 
Preoperative ventilation 3.9 (1.9 – 8.0) <0.001 
Single ventricle anatomy 4.0 (2.0 – 7.9) <0.001 
Residual cardiac lesion 4.8 (2.1 – 10.9) <0.001 
Peak VVR score in 1st 12 hours 1.06 (1.03 – 1.08) <0.001 
VVR: vasoactive-ventilation-renal score 
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Figure Legends  
Figure 1:  Receiver Operating Characteristic (ROC) curves for prolonged duration of 
mechanical ventilation. Exposure variables are STAT Mortality Category, duration of 
cardiopulmonary bypass (CPB), and peak serum lactate, vasoactive-inotrope score (VIS), 
ventilation index, and vasoactive-ventilation-renal (VVR) score at 12 hours postoperatively. The 
AUC was greatest for the VVR at 12 hours postoperatively, P<0.001 for all comparisons. 
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Figure 2: Receiver Operating Characteristic (ROC) curves for prolonged duration of mechanical 
ventilation. Depicted are the multivariable model and its individual components: vasoactive-
ventilation-renal (VVR) score at 12 hours postoperatively, delayed sternal closure, inhaled nitric 
oxide use, and postoperative arrhythmias, and prematurity.  Area under the curve was 0.90 
(95% CI: 0.86, 0.94) for the multivariable model and 0.92 (95% CI: 0.89,0.96) for the mixed 
model (which included adjustment for center). 
 
